RTI Surgical Insider ownership
What is the Insider ownership of RTI Surgical?
The Insider ownership of RTI Surgical Holdings, Inc. is 11.17%
What is the definition of Insider ownership?
Insider Ownership is calculated as the total number of shares owned by insiders (shareholders who own more than 5% of the corporation or an officer or director of the company) divided by the total Shares Outstanding.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Insider ownership of companies in the Health Care sector on NASDAQ compared to RTI Surgical
What does RTI Surgical do?
RTI Surgical Holdings, Inc. engages in the provision of biologic, metal, and synthetic-based surgical implants. It offers implants in the following categories: extremities, orthobiologics, spine, sports medicine, and surgical specialties. The company was founded in February 1998 and is headquartered in Deerfield, IL.
Companies with insider ownership similar to RTI Surgical
- Huntsman Exploration Inc has Insider ownership of 11.14%
- BlueBird Battery Metals has Insider ownership of 11.14%
- China e-Wallet Payment has Insider ownership of 11.14%
- Integral Diagnostics has Insider ownership of 11.15%
- QinetiQ plc has Insider ownership of 11.15%
- Lonestar Resources US has Insider ownership of 11.15%
- RTI Surgical has Insider ownership of 11.17%
- The Star Entertainment has Insider ownership of 11.17%
- Dixie has Insider ownership of 11.17%
- SoFi Technologies has Insider ownership of 11.18%
- Sanofi has Insider ownership of 11.18%
- Sanofi has Insider ownership of 11.18%
- Corcept Therapeutics Inc has Insider ownership of 11.18%